Skip to content

Training of Neural Responding in BPD

Training of Neural Responding in BPD - IP5n

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00009363
Enrollment
25
Registered
2016-06-21
Start date
2016-11-03
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F60.31

Interventions

Group 1: Treatment group: 25 patients with BPD. In a diagnostic session, diagnostics of psychiatric disorders are conducted. For BPD diagnosis, the International Personality Disorder Examination (IPDE

Sponsors

Department of Psychosomatic Medicine and Psychotherapy, Central Institute of Mental Health
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Current BPD (= 4 DSM-V criteria), female, informed consent for study participation

Exclusion criteria

Exclusion criteria: Psychotropic medication with tranquilizers, lifetime diagnosis of schizophrenia or bipolar I, substance dependence in the preceding year, current substance use, pregnancy, epilepsy, antecedent cranial or brain injuries, organic brain diseases, severe medical or neurological condition, BMI<16.5, metallic non-removable items in or on the body which are not MR compatible, permanent make-up, claustrophobia, left-handedness

Design outcomes

Primary

MeasureTime frame
Target criterion: Improvement of emotion regulation. Measures: Questionnaire: Difficulties in Emotion Regulation Scale (DERS); Peripheral physiologic measures: Fear-potentiated startle with instructed emotion regulation vs. natural responding to emotional pictures, heart rate variability (relation of high vs. low frequencies in spectrum). Central nervous system measures: amygdala BOLD response to masked affective facial expressions, amygdala BOLD response in Sternberg-Working Memory test with emotional vs. neutral distractor images. Acquisition times: T0: Treatment group: max 7 days before first training session (depends on patient's availability), T1: max 7 days after third training session, T2 (Follow up): 6 weeks after T1

Secondary

MeasureTime frame
Target criterion: Reduction of BPD symptom severity. Measures: ZAN-BPD structured interview (acquisition in T0 and T2), BSL-23 self-report questionnaire (acquisition in T0, T1, T2; time lag matched to treatment group).

Countries

Germany

Contacts

Public ContactChristian Paret

Central Institute of Mental Health

christian.paret@zi-mannheim.de++49-621-1703-4462

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026